Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 77 of the 77 references it cites were found in a registry or an index.

Lipophilic statins inhibit YAP nuclear localization, co-activator activity and colony formation in pancreatic cancer cells and prevent the initial stages of pancreatic ductal adenocarcinoma in KrasG12D mice

Open access
Hao, Fang, Xu, Qinhong, Wang, Jing, Yu, Shuo, Chang, Hui-Hua, Sinnett-Smith, James, Eibl, Guido, Rozengurt, Enrique · 2019 · PLOS ONE

Abstract

We examined the impact of statins on Yes-associated Protein (YAP) localization, phosphorylation and transcriptional activity in human and mouse pancreatic ductal adenocarcinoma (PDAC) cells. Exposure of sparse cultures of PANC-1 and MiaPaCa-2 cells to cerivastatin or simvastatin induced a striking re-localization of YAP from the nucleus to the cytoplasm and inhibited the expression of the YAP/TEAD-regulated genes Connective Tissue Growth Factor (CTGF) and Cysteine-rich angiogenic inducer 61 (CYR61). Statins also prevented YAP nuclear import and expression of CTGF and CYR61 stimulated by the mitogenic combination of insulin and neurotensin in dense culture of these PDAC cells. Cerivastatin, simvastatin, atorvastatin and fluvastatin also inhibited colony formation by PANC-1 and MiaPaCa-2 cells in a dose-dependent manner. In contrast, the hydrophilic statin pravastatin did not exert any inhibitory effect even at a high concentration (10 μM). Mechanistically, cerivastatin did not alter the phosphorylation of YAP at Ser127 in either PANC-1 or MiaPaCa-2 cells incubated without or with neurotensin and insulin but blunted the assembly of actin stress fiber in these cells. We extended these findings with human PDAC cells using primary KC and KPC cells, (expressing KrasG12D or both KrasG12D and mutant p53, respectively) isolated from KC or KPC mice. Using cultures of these murine cells, we show that lipophilic statins induced striking YAP translocation from the nucleus to the cytoplasm, inhibited the expression of Ctgf, Cyr61 and Birc5 and profoundly inhibited colony formation of these cells. Administration of simvastatin to KC mice subjected to diet-induced obesity prevented early pancreatic acini depletion and PanIN formation. Collectively, our results show that lipophilic statins restrain YAP activity and proliferation in pancreatic cancer cell models in vitro and attenuates early lesions leading to PDAC in vivo.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0216603

Cites

77 of 77 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig 1 Statins induce re-distribution of YAP to the cytoplasm and inhibit YAP/TEAD-regulated genes in PDAC cells. A, PANC-1 and Mia PaCa-2 cells were fixed with 4% paraformaldehyde 1, 3 and 7 days after plating, as indicated. B, PANC-1 and Mia PaCa-2 cells were incubated in either absence or presence of 0.3 μM cerivastatin (Cer) added 1 day after plating and for 24 h. either with or without 250 μM mevalonic acid Then, the cells were fixed with 4% paraformaldehyde. In A and B the cultures were stained with an antibody that detects total YAP. Bars represent the ratio of nuclear/cytoplasm (50 to 75 cells) mean ± S.E. with similar results obtained in three independent experiments (T-test p values comparing the indicated groups to control were **p<0.01). C and D, PANC-1 and MiaPaCa-2 cells were incubated in either absence or presence of cerivastatin (Cer) at 0.1 and 1 μM or simvastatin (sim) at 0.3 and 3 μM, as indicated. Statins were added 1 day after plating and the incubation continued for 24 h. RNA was then isolated and the relative levels (n = 3) of CTGF (C) or CYR61 (D) mRNA compared with 18s mRNA was measured by RT-qPCR. Data are presented as mean ± SEM of 5 independent experiments for CTGF and 3 independent experiments for CYR61. Cerivastatin and simvastatin groups vs control *p<0.05, **p<0.01.
Fig 1 Statins induce re-distribution of YAP to the cytoplasm and inhibit YAP/TEAD-regulated genes in PDAC cells. A, PANC-1 and Mia PaCa-2 cells were fixed with 4% paraformaldehyde 1, 3 and 7 days after plating, as indicated. B, PANC-1 and Mia PaCa-2 cells were incubated in either absence or presence of 0.3 μM cerivastatin (Cer) added 1 day after plating and for 24 h. either with or without 250 μM mevalonic acid Then, the cells were fixed with 4% paraformaldehyde. In A and B the cultures were stained with an antibody that detects total YAP. Bars represent the ratio of nuclear/cytoplasm (50 to 75 cells) mean ± S.E. with similar results obtained in three independent experiments (T-test p values comparing the indicated groups to control were **p<0.01). C and D, PANC-1 and MiaPaCa-2 cells were incubated in either absence or presence of cerivastatin (Cer) at 0.1 and 1 μM or simvastatin (sim) at 0.3 and 3 μM, as indicated. Statins were added 1 day after plating and the incubation continued for 24 h. RNA was then isolated and the relative levels (n = 3) of CTGF (C) or CYR61 (D) mRNA compared with 18s mRNA was measured by RT-qPCR. Data are presented as mean ± SEM of 5 independent experiments for CTGF and 3 independent experiments for CYR61. Cerivastatin and simvastatin groups vs control *p<0.05, **p<0.01.CC0 · PubMed Central
Fig 2 Cerivastatin inhibits YAP nuclear localization induced by stimulation with neurotensin and insulin in confluent PDAC cells. Confluent cultures of PANC-1 (A) or Mia PaCa-2 (B) cells were incubated either in the absence or presence of 0.3μM cerivastatin (Cer) for 24 h. The cultures were then stimulated without (-) or with a combination of 5 nM neurotensin and 10 ng/ml insulin (NT+Ins) for 60 min. The cultures were then washed, fixed with 4% paraformaldehyde and stained with an antibody that detects total YAP and with Hoechst 33342 to visualize the cell nuclei. Bars represent the ratio of nuclear/cytoplasm (100 to 125 cells). Cerivastatin significantly decreased NT+Ins nuclear localization of YAP as compared with untreated controls (**P < 0.01) as shown by t-test.
Fig 2 Cerivastatin inhibits YAP nuclear localization induced by stimulation with neurotensin and insulin in confluent PDAC cells. Confluent cultures of PANC-1 (A) or Mia PaCa-2 (B) cells were incubated either in the absence or presence of 0.3μM cerivastatin (Cer) for 24 h. The cultures were then stimulated without (-) or with a combination of 5 nM neurotensin and 10 ng/ml insulin (NT+Ins) for 60 min. The cultures were then washed, fixed with 4% paraformaldehyde and stained with an antibody that detects total YAP and with Hoechst 33342 to visualize the cell nuclei. Bars represent the ratio of nuclear/cytoplasm (100 to 125 cells). Cerivastatin significantly decreased NT+Ins nuclear localization of YAP as compared with untreated controls (**P < 0.01) as shown by t-test.CC0 · PubMed Central
Fig 3 Exposure to lipophilic statins inhibits the expression of CTGF and CYR61 induced by stimulation with neurotensin and insulin in PDAC cells. Confluent cultures of PANC-1 cells (upper panel) or MiaPaca-2 cells (lower panel) were incubated for 24 h either without or with cerivastatin (Cer) at 0.1 and 0.3 μM or simvastatin (sim) at 3 and 10 μM, as indicated. The cultures were then stimulated either without (-) or with a combination of 5 nM neurotensin and 10 ng/ml insulin (NT+Ins) for 60 min. RNA was isolated and the relative levels (n = 3) of CTGF or CYR61 mRNA compared with 18s mRNA was measured by RT-qPCR. Data are presented as mean ± SEM. Similar results were obtained in 3 independent experiments. Exposure to cerivastatin and simvastatin significantly decreased relative mRNA levels of CTGF and CYR61 as compared with controls (**P < 0.01) as shown by paired t-test.
Fig 3 Exposure to lipophilic statins inhibits the expression of CTGF and CYR61 induced by stimulation with neurotensin and insulin in PDAC cells. Confluent cultures of PANC-1 cells (upper panel) or MiaPaca-2 cells (lower panel) were incubated for 24 h either without or with cerivastatin (Cer) at 0.1 and 0.3 μM or simvastatin (sim) at 3 and 10 μM, as indicated. The cultures were then stimulated either without (-) or with a combination of 5 nM neurotensin and 10 ng/ml insulin (NT+Ins) for 60 min. RNA was isolated and the relative levels (n = 3) of CTGF or CYR61 mRNA compared with 18s mRNA was measured by RT-qPCR. Data are presented as mean ± SEM. Similar results were obtained in 3 independent experiments. Exposure to cerivastatin and simvastatin significantly decreased relative mRNA levels of CTGF and CYR61 as compared with controls (**P < 0.01) as shown by paired t-test.CC0 · PubMed Central
Fig 4 Lipophilic statins inhibit colony-formation by PDAC cells. Colony formation assays were performed as described in the Materials and Methods section. PANC-1 or MiaPaCa-2 cells were incubated for 10 days (PANC-1 cells) or 8 days (Mia PaCa-2 cells) with various concentrations of lipophilic statins, such as cerivastatin, simvastatin, atorvastatin, fluvastatin or the hydrophilic statin pravastatin, as indicated. Typical pictures are shown for selected conditions The bars represent the number of colonies (mean ± SEM; n = 4 dishes per condition). Similar results were obtained in 6 independent experiments for cerivastatin, 4 for simvastatin and 3 for atorvastatin, fluvastatin and pravastatin.
Fig 4 Lipophilic statins inhibit colony-formation by PDAC cells. Colony formation assays were performed as described in the Materials and Methods section. PANC-1 or MiaPaCa-2 cells were incubated for 10 days (PANC-1 cells) or 8 days (Mia PaCa-2 cells) with various concentrations of lipophilic statins, such as cerivastatin, simvastatin, atorvastatin, fluvastatin or the hydrophilic statin pravastatin, as indicated. Typical pictures are shown for selected conditions The bars represent the number of colonies (mean ± SEM; n = 4 dishes per condition). Similar results were obtained in 6 independent experiments for cerivastatin, 4 for simvastatin and 3 for atorvastatin, fluvastatin and pravastatin.CC0 · PubMed Central
Fig 5 Mechanism of action of statins in PDAC cells. A, The geranylgeranyl transferase inhibitor GGTI 298 inhibits colony formation by PDAC cells. Colony formation assays were performed as described in the Materials and Methods section. PANC-1 or MiaPaCa-2 cells were incubated for 10 days (PANC-1 cells) or 8 days (Mia PaCa-2 cells) with or without GGTI 298 at the indicated concentrations. The bars represent the number of colonies (mean ± SEM; n = 4 dishes per condition). B and C, Treatment with cerivastatin does not alter YAP phosphorylation at Ser127. PANC-1 (B) and Mia PaCa-2 (C) cells were treated for 24 h either in the absence or presence of cerivastatin (Cer, 0.3 μM) for 24h. The cultures were then stimulated with 5 nM neurotensin and 10 ng/ml insulin (NT+Ins) for 30 min as indicated, and lysed with SDS–PAGE sample buffer. The samples were analyzed by SDS-PAGE and immunoblotting with YAP Ser127 and YAP antibodies. Quantification of phosphorylated YAP Ser127 was performed using Multi Gauge V3.0. from 9 independent experiments, T-test p values comparing the indicated groups to control were * p< 0.05; **p < .0.01. D and E, Exposure to either cerivastatin or simvastatin does not alter YAP phosphorylation at Ser127. PANC-1 and Mia PaCa-2 cells were treated for 24 h either in the absence or presence of cerivastatin (Cer) or simvastatin (Sim) at the indicated concentrations (in μM) for 24h. The cultures were then stimulated with 5 nM neurotensin and 10 ng/ml insulin (NT+Ins) for 30 min as indicated, and lysed with SDS–PAGE sample buffer. The samples were analyzed by SDS-PAGE and immunoblotting with antibodies that detect phospho YAP Ser127, YAP, phospho LATS Thr1079 and LATS2 antibodies. Equal loading was verified by immunoblotting with actin antibody. Similar results were obtained in 4 independent experiments. F and G, Cerivastatin inhibits the assembly of actin stress fibers induced by stimulation with insulin and neurotensin. PANC-1 (F) and Mia PaCa-2 cells (G) were treated for 24 h either in the absence or presence of cerivastatin at the indicated concentrations for 24h prior to stimulation with 5 nM neurotensin and 10 ng/ml insulin (NT+Ins) for 30 min. The cultures were then washed, fixed with 4% paraformaldehyde, and stained with TRITC-conjugated phalloidin and Hoechst 33342. Similar results were obtained in 3 independent experiments.
Fig 5 Mechanism of action of statins in PDAC cells. A, The geranylgeranyl transferase inhibitor GGTI 298 inhibits colony formation by PDAC cells. Colony formation assays were performed as described in the Materials and Methods section. PANC-1 or MiaPaCa-2 cells were incubated for 10 days (PANC-1 cells) or 8 days (Mia PaCa-2 cells) with or without GGTI 298 at the indicated concentrations. The bars represent the number of colonies (mean ± SEM; n = 4 dishes per condition). B and C, Treatment with cerivastatin does not alter YAP phosphorylation at Ser127. PANC-1 (B) and Mia PaCa-2 (C) cells were treated for 24 h either in the absence or presence of cerivastatin (Cer, 0.3 μM) for 24h. The cultures were then stimulated with 5 nM neurotensin and 10 ng/ml insulin (NT+Ins) for 30 min as indicated, and lysed with SDS–PAGE sample buffer. The samples were analyzed by SDS-PAGE and immunoblotting with YAP Ser127 and YAP antibodies. Quantification of phosphorylated YAP Ser127 was performed using Multi Gauge V3.0. from 9 independent experiments, T-test p values comparing the indicated groups to control were * p< 0.05; **p < .0.01. D and E, Exposure to either cerivastatin or simvastatin does not alter YAP phosphorylation at Ser127. PANC-1 and Mia PaCa-2 cells were treated for 24 h either in the absence or presence of cerivastatin (Cer) or simvastatin (Sim) at the indicated concentrations (in μM) for 24h. The cultures were then stimulated with 5 nM neurotensin and 10 ng/ml insulin (NT+Ins) for 30 min as indicated, and lysed with SDS–PAGE sample buffer. The samples were analyzed by SDS-PAGE and immunoblotting with antibodies that detect phospho YAP Ser127, YAP, phospho LATS Thr1079 and LATS2 antibodies. Equal loading was verified by immunoblotting with actin antibody. Similar results were obtained in 4 independent experiments. F and G, Cerivastatin inhibits the assembly of actin stress fibers induced by stimulation with insulin and neurotensin. PANC-1 (F) and Mia PaCa-2 cells (G) were treated for 24 h either in the absence or presence of cerivastatin at the indicated concentrations for 24h prior to stimulation with 5 nM neurotensin and 10 ng/ml insulin (NT+Ins) for 30 min. The cultures were then washed, fixed with 4% paraformaldehyde, and stained with TRITC-conjugated phalloidin and Hoechst 33342. Similar results were obtained in 3 independent experiments.CC0 · PubMed Central
Fig 6 Statins inhibit YAP nuclear localization, colony formation and the expression of Ctgf, Cyr61 and Birc5 in KC cells. A, KC cells 1 day after plating were incubated either in absence or presence of 0.3 μM cerivastatin (Cer) or 3 μM simvastatin (Ser) for 24 h. Then, the cells were then fixed with 4% paraformaldehyde and stained with an antibody that detects total YAP and with Hoechst 33342 to visualize the cell nuclei. Bars represent the ratio of nuclear/cytoplasm (50 to 75 cells). **P 0.01 as shown by paired t-test. B, KC cells were incubated either in absence or presence of cerivastatin (Cer) or simvastatin (Sim) at the indicated concentrations. Statins were added 1 day after plating and the incubation continued for 24 h. RNA was then isolated and the relative levels (n = 3) of Ctgf, Cyr61 and Birc5 mRNA compared with 18s mRNA were measured by RT-qPCR. Data are presented as mean ± SEM. Similar results were obtained in 3 independent experiments. C, KC cells were incubated for 6 days with various concentrations of cerivastatin or simvastatin, as indicated. The bars represent the number of colonies (mean ± SEM; n = 4 cultures per condition).
Fig 6 Statins inhibit YAP nuclear localization, colony formation and the expression of Ctgf, Cyr61 and Birc5 in KC cells. A, KC cells 1 day after plating were incubated either in absence or presence of 0.3 μM cerivastatin (Cer) or 3 μM simvastatin (Ser) for 24 h. Then, the cells were then fixed with 4% paraformaldehyde and stained with an antibody that detects total YAP and with Hoechst 33342 to visualize the cell nuclei. Bars represent the ratio of nuclear/cytoplasm (50 to 75 cells). **P 0.01 as shown by paired t-test. B, KC cells were incubated either in absence or presence of cerivastatin (Cer) or simvastatin (Sim) at the indicated concentrations. Statins were added 1 day after plating and the incubation continued for 24 h. RNA was then isolated and the relative levels (n = 3) of Ctgf, Cyr61 and Birc5 mRNA compared with 18s mRNA were measured by RT-qPCR. Data are presented as mean ± SEM. Similar results were obtained in 3 independent experiments. C, KC cells were incubated for 6 days with various concentrations of cerivastatin or simvastatin, as indicated. The bars represent the number of colonies (mean ± SEM; n = 4 cultures per condition).CC0 · PubMed Central
Fig 7 Simvastatin prevents the disruption in histologic pancreatic architecture induced by DIO in KC mice. A and B, Representative H&E staining of the pancreas of a KC mouse fed the HFCD (A) or HFCD plus simvastatin (B). C, Percentage (%) of intact acini in KC mice fed the CD, HFCD or HFCD plus simvastatin at 3 months. D, Pancreatitis score in KC mice fed CD, HFCD or HFCD plus simvastatin at 3 months. E, Percentage (%) of PanIN-3 lesions in KC mice fed CD, HFCD or HFCD plus simvastatin at 3 months. F, Simvastatin has no effect on weight gain in KC mice fed with either CD, HFCD, or HFCD plus simvastatin at 3 months. The number of mice used were: CD = 10; HFCD = 14; HFCD+simvastatin = 14. Values are means ± s.d. *p < 0.05 vs. CD, #p < 0.05 vs. HFCD.
Fig 7 Simvastatin prevents the disruption in histologic pancreatic architecture induced by DIO in KC mice. A and B, Representative H&E staining of the pancreas of a KC mouse fed the HFCD (A) or HFCD plus simvastatin (B). C, Percentage (%) of intact acini in KC mice fed the CD, HFCD or HFCD plus simvastatin at 3 months. D, Pancreatitis score in KC mice fed CD, HFCD or HFCD plus simvastatin at 3 months. E, Percentage (%) of PanIN-3 lesions in KC mice fed CD, HFCD or HFCD plus simvastatin at 3 months. F, Simvastatin has no effect on weight gain in KC mice fed with either CD, HFCD, or HFCD plus simvastatin at 3 months. The number of mice used were: CD = 10; HFCD = 14; HFCD+simvastatin = 14. Values are means ± s.d. *p < 0.05 vs. CD, #p < 0.05 vs. HFCD.CC0 · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 77 references

Research works printed but not linked: 2

  1. T Hamada, 2018, Pre-diagnosis Use of Statins Associates With Increased Survival Times of Patients With Pancreatic Cancer, Clin Gastroenterol Hepatol
  2. S Yang, 2015, Active YAP promotes pancreatic cancer cell motility, invasion and tumorigenesis in a mitotic phosphorylation-dependent manner through LPAR3, 10.18632/oncotarget.5935 · DOI

Cited by

See all 57

Metadata

Authors
Hao, F., Xu, Q., Wang, J., Yu, S., Chang, H.-H., Sinnett-Smith, J., Eibl, G., & Rozengurt, E.
Affiliations
University of California, Los Angeles (US)
Corresponding author
Rozengurt, Enrique
Venue
PLOS ONE
Published
2019-05-17
Volume
14
Issue
5
Pages
e0216603
ISSN
1932-6203 (ISSN-L)
OpenAlex
W2945457209
Cited by
55
References
77
Citations by year
2026: 3 · 2025: 5 · 2024: 11 · 2023: 10 · 2022: 9 · 2021: 6 · 2020: 9 · 2019: 2
FWCI
3.44
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, public-domain)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • eScholarship (California Digital Library) (submittedVersion)
  • eScholarship (California Digital Library) (submittedVersion, public-domain)
  • Figshare (submittedVersion, cc-by)
Funders
  • National Institute of Diabetes and Digestive and Kidney Diseases (R01DK100405, P30DK041301)
  • National Cancer Institute (P01CA163200)
  • U.S. Department of Veterans Affairs (I01BX003801)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Hippo pathway signaling and YAP/TAZ
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
  • Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
Keywords
lipophilic statins, YAP, pancreatic ductal adenocarcinoma, cerivastatin, simvastatin, YAP nuclear localization, YAP phosphorylation, connective tissue growth factor, CYR61, survivin, colony formation, stress fibers, KRAS G12D, KPC mice, pancreatic intraepithelial neoplasia, diet-induced obesity
MeSH terms
YAP-Signaling Proteins, Animals, Cell Nucleus, Colony-Forming Units Assay, Humans, Mutation, Pancreatic Neoplasms, Phosphorylation, Transcription Factors, Tumor Cells, Cultured, Gene Expression Regulation, Neoplastic, Proto-Oncogene Proteins p21(ras), Hydroxymethylglutaryl-CoA Reductase Inhibitors, Protein Transport, Carcinoma, Pancreatic Ductal, Adaptor Proteins, Signal Transducing, Cell Proliferation, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Lipophilic statins inhibit YAP nuclear localization, co-activator activity and colony formation in pancreatic cancer cells and prevent the initial stages of pancreatic ductal adenocarcinoma in KrasG12D mice. https://app.cochat.ai/papers/10.1371/journal.pone.0216603
The paper
Hao, F., Xu, Q., Wang, J., Yu, S., Chang, H.-H., Sinnett-Smith, J., Eibl, G., & Rozengurt, E. (2019). Lipophilic statins inhibit YAP nuclear localization, co-activator activity and colony formation in pancreatic cancer cells and prevent the initial stages of pancreatic ductal adenocarcinoma in KrasG12D mice. PLOS ONE. https://doi.org/10.1371/journal.pone.0216603

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.